Use access key #2 to skip to page content.
$10.27 -0.63 (-5.78%)
1/9/2009 4:00 PM

Alkermes, Inc. (ALKS)

CAPS Rating:
****

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

View All Commentary (ALKS)

Recs

1

Avatar stratton6 (99.60) Submitted: 8/06/06 5:08 PM : Outperform Start Price: $16.93 ALKS Score: -8.99

Drug delivery technologies, inhalation and extended release microspheres. This will be a hottly competitive market in the comming years. Alkermes has a few good collaborations.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links